CT vs MRCP: Optimal Classification of IPMN Type and Extent
- 814 Downloads
Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are being diagnosed with increased frequency. CT scanning commonly serves as the primary imaging modality before surgery. We hypothesized MRCP provides better characterization of IPMN type/extent, which more closely matches actual pathology.
Of 214 patients treated with IPMN (1991–2006), 30 had both preoperative CT and MRCP. Of these, 18 met imaging study criteria. Independent readers performed retrospective, blinded analyses using standardized criteria for IPMN type and extent.
A ductal connection was detected on 73% of MRCP scans and only 18% of CT. IPMN type was classified differently in seven (39%); four (22%) of which were read on CT as having main duct involvement where this was not appreciated on MRCP or found on surgical pathology. MRCP showed multifocal disease in 13(72%) versus only 9(50%) on CT. A different disease distribution was seen in 9(50%). Finally, 101 branch lesions were identified on MRCP compared to 46 on CT.
CT falls short of MRCP in detecting a ductal connection, estimating main duct involvement, and identification of small branch duct cysts. These factors influence diagnostic accuracy, cancer risk stratification and operative strategy. MRCP should be employed for optimal management of patients with IPMN.
KeywordsIntraductal papillary mucinous neoplasm Magnetic resonance cholangiopancreatography Computed tomography
This work was supported by the NIH 1R03CA112629-01A1 (CMS).
- 1.Ohhashi K, Murakimi Y, Maruyama M, Takekoshi T, Ohta H, Ohhashi I. Four cases of mucous secreting pancreatic cancer [in Japanese]. Prog Dig Endosc 1982;20:348–351.Google Scholar
- 3.Schmidt CM, Wiesenauer CA, Cummings OW, Yiannoutsos CT, Howard TJ, Wiebke EA, Goulet RJ Jr, McHenry LH, Sherman S, Lehman GA, Cramer H, Madura JA. Preoperative Predictors of Malignancy in Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMN). Arch Surg 2003;138:610–618.PubMedCrossRefGoogle Scholar
- 6.Salvia R, Fernandez-del Castillo C, Bassi C, Thayer SP, Falconi M, Mantovani W, Pederzoli P, Warshaw AL. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 2004;239(5):678–687.PubMedCrossRefGoogle Scholar
- 10.Tanaka M, Chari S, Adsay V, Fernandez-Del Castillo C, Falconi M, Shimizu M, Yamaguchi K, Yamao K, Matsuno S. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006;6(1–2):17–32.PubMedCrossRefGoogle Scholar
- 13.Cellier C, Cuillerier E, Palazzo L, et al Intraductal papillary and mucinous tumors of the pancreas: accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasonography, and long-term outcome in a large surgical series. Gastrointest Endosc 1998;47:42–49.PubMedCrossRefGoogle Scholar
- 21.White PB, Waters JA, Baker M, Cummings OW, Howard TJ, Pitt HA, Zyromski NJ, Nakeeb A, Lillemoe KD, Schmidt CM. Intraductal Papillary Mucinous Neoplasms (IPMN): Factors Predicting Malignancy. Ann Surg 2007 (in press).Google Scholar
- 22.Chari ST, Yadav D, Smyrk TC, DiMagno EP, Miller LJ, Raimondo M, Clain JE, Norton IA, Pearson RK, Petersen BT, Wiersema MJ, Farnell MB, Sarr MG. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology 2002;123(5):1500–1507.PubMedCrossRefGoogle Scholar
- 23.Irie H, Yoshimitsu K, Aibe H, Tajima T, Nishie, Akihiro, Nakayama T, Kakihara D, Honda H. Natural history of pancreatic intraductal papillary mucinous tumor of branch duct type: Follow-up study by magnetic resonance cholangiopancreatography. J Comput Assist Tomogr 2004;28(1):117–122.PubMedCrossRefGoogle Scholar